Stocks · Healthcare · Medical - Instruments & Supplies
AngioDynamics, Inc. ANGO
$15.11 -0.07% Close, Oct 2, 2026 · NASDAQ · Market cap $624.5M
Low risk
Next earnings report: Oct 8, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in an uptrend: above its 200-day average for 84 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $320.2M, up 9.5% from a year earlier.
- The company holds net cash of $53.9M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 48%
- Revenue growth, 3-year CAGRBottom 20%
- Revenue growth accelerationBottom 39%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 49%
- Gross marginBottom 39%
- Operating marginBottom 46%
- Accruals (lower is better)Top 23%
- Interest coverBottom 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 45%
- Free-cash-flow yieldTop 36%
- EBITDA / enterprise valueBottom 47%
- Sales / enterprise valueTop 22%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 38%
- 6-month returnTop 21%
- 1-year return vs S&P 500Top 32%
- Distance from 52-week highTop 10%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 34%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 13%
- Upside to consensus price targetBottom 35%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 14%
- Maximum drawdown, 3 yearsTop 8%
- Beta vs S&P 500 (lower is better)Top 6%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.7% | 9.5% | ↓ |
| Gross margin | 53.9% | 54.6% | ↑ |
| Operating margin | -13.7% | -12.5% | ↑ |
| FCF margin | -5.0% | 0.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 9.5% | 10.7% | ↓ | Top 48% |
| Gross margin | 54.6% | 53.9% | ↑ | Bottom 39% |
| Operating margin | -12.5% | -13.7% | ↑ | Bottom 46% |
| Net margin | -11.5% | -11.6% | ↑ | — |
| Free-cash-flow margin | 0.2% | -5.0% | ↑ | — |
| Return on invested capital | -20.7% | — | Bottom 49% | |
| Revenue growth, 3-year CAGR | -1.9% | — | Bottom 20% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -14.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +2.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -133.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- +1.3%
- Share count change, 3-year CAGR
- +1.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through May 31, 2026 (filed Jul 14, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +12.8%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $19.50
- Target vs current price
- +29.1%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 45%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 14, 2026 | +36.4% | +1.7% | +7.3% | +23.2% | — |
| Apr 2, 2026 | +36.4% | -13.7% | -15.5% | -8.4% | +10.6% |
| Jan 6, 2026 | -50.0% | -13.5% | -23.1% | -19.6% | -9.8% |
| Oct 2, 2025 | +28.6% | +6.1% | +0.5% | +9.5% | +18.3% |
| Jul 15, 2025 | +76.9% | -10.2% | -6.6% | -12.3% | +14.7% |
| Apr 2, 2025 | +123.1% | +12.4% | -6.8% | -3.8% | +1.2% |
| Jan 8, 2025 | +63.6% | +37.7% | +29.5% | +18.1% | -3.1% |
| Oct 3, 2024 | +26.7% | -16.7% | -20.5% | -9.4% | +16.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 14, 2026 | -$0.07 | -$0.11 | +36.4% | $86.6M |
| Apr 2, 2026 | -$0.07 | -$0.11 | +36.4% | $78.4M |
| Jan 6, 2026 | -$0.15 | -$0.10 | -50.0% | $79.4M |
| Oct 2, 2025 | -$0.10 | -$0.14 | +28.6% | $75.7M |
| Jul 15, 2025 | -$0.03 | -$0.13 | +76.9% | $80.2M |
| Apr 2, 2025 | $0.03 | -$0.13 | +123.1% | $72.0M |
| Jan 8, 2025 | -$0.04 | -$0.11 | +63.6% | $72.8M |
| Oct 3, 2024 | -$0.11 | -$0.15 | +26.7% | $67.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.78× | — | — | Top 22% |
| Free-cash-flow yield | 0.08% | — | — | Top 36% |
| Earnings yield | -5.82% | — | — | Top 45% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 84
- 50-day average slope (20 days)
- +5.6%
- 200-day average slope (20 days)
- +2.2%
- Distance from 50-day average
- -1.9%
- Distance from 200-day average
- +21.1%
- RSI (14)
- 43.1
- Relative volume
- 2.15×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 34.0%
- Volatility vs own 5-year history
- 7th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.22
- Correlation with S&P 500
- 0.07
- Current drawdown from 1-year high
- -6.3%
- Maximum drawdown, 3 years
- -35.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 5, 2021 | Mar 25, 2024 | -83.0% | 597 days | Not yet recovered |
| Sep 1, 2021 | Sep 29, 2021 | -20.0% | 19 days | 23 days (Nov 1, 2021) |
| Sep 29, 2020 | Oct 30, 2020 | -18.8% | 23 days | 17 days (Nov 24, 2020) |
| Jul 12, 2021 | Jul 19, 2021 | -12.8% | 5 days | 30 days (Aug 30, 2021) |
| Mar 17, 2021 | Mar 24, 2021 | -11.3% | 5 days | 5 days (Mar 31, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $624.5M
- EPS, diluted (TTM)
- -$0.88
- Revenue (TTM)
- $320.2M
- 52-week range
- $9.39 – $16.29
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $316.2M | $338.8M | $303.9M | $292.5M | $320.2M |
| Gross profit | $165.7M | $174.2M | $154.7M | $157.7M | $174.9M |
| Operating income | -$28.5M | -$51.2M | -$192.4M | -$40.0M | -$39.9M |
| Net income | -$26.5M | -$52.4M | -$184.3M | -$34.0M | -$36.7M |
| EPS (diluted) | -$0.68 | -$1.33 | -$4.59 | -$0.83 | -$0.88 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.5M | $72.8M | $72.0M | $80.2M | $75.7M | $79.4M | $78.4M | $86.6M |
| Net income | -$12.8M | -$10.7M | -$4.4M | -$6.0M | -$10.9M | -$6.3M | -$8.1M | -$11.4M |
| EPS (diluted) | -$0.31 | -$0.26 | -$0.11 | -$0.15 | -$0.26 | -$0.15 | -$0.19 | -$0.28 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | -$7.2M | $78,000 | -$28.2M | -$10.1M | $3.1M |
| Capital expenditure | -$4.3M | -$4.4M | -$5.8M | -$4.5M | -$2.6M |
| Free cash flow | -$11.5M | -$4.3M | -$33.9M | -$14.6M | $508,000 |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $2.7M | $1.2M | $752,000 | -$1.7M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $53.9M
- Total assets
- $267.2M
- Total liabilities
- $96.3M
- Total debt
- $0
- Net debt
- -$53.9M
- Shareholders’ equity
- $170.8M
As of May 31, 2026 (filed Jul 14, 2026).
Short interest
- Shares sold short
- 1,343,344
- Days to cover
- 3.48
- Change vs previous report
- -1.5%
FINRA short interest, settlement date Sep 15, 2026.